| Literature DB >> 25425257 |
E Mulder1, G Clément, D Linnarsson, W H Paloski, F P Wuyts, J Zange, P Frings-Meuthen, B Johannes, V Shushakov, M Grunewald, N Maassen, J Buehlmeier, J Rittweger.
Abstract
OBJECTIVES: The present study evaluated the effectiveness of a short and versatile daily exercise regime, named locomotion replacement training (LRT), to maintain muscle size, isometric strength, power, and endurance capacity of the leg muscles following 5 days of head-down tilt (HDT) bed rest.Entities:
Mesh:
Year: 2014 PMID: 25425257 PMCID: PMC4359292 DOI: 10.1007/s00421-014-3045-0
Source DB: PubMed Journal: Eur J Appl Physiol ISSN: 1439-6319 Impact factor: 3.078
Subject characteristics at baseline
| Age (years) | Height (cm) | Body mass (kg) | Body fat (%) | |
|---|---|---|---|---|
| CON | 29.7 ± 6.0 | 178.8 ± 4.8 | 77.8 ± 4.8 | 18.8 ± 3.7 |
| STA | 29.6 ± 5.8 | 178.8 ± 4.8 | 78.1 ± 4.9 | 18.8 ± 3.3 |
| LRT | 29.6 ± 5.8 | 178.8 ± 4.8 | 78.0 ± 5.0 | 18.4 ± 4.1 |
Body fat (%) is based on whole-body dual energy X-ray absorptiometry (DEXA)
CON bed rest only, STA upright standing, LRT locomotion replacement training
Knee extensor and plantar flexor size and function for CON, STA, and LRT before (Pre) and after (Post) 5 days of bed rest
| Variable | CON | STA | LRT | |||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| Knee extensors | ||||||
| max CSA (mm2) | 7,835 ± 227 | 7,665 ± 218*** | 7,875 ± 231 | 7,669 ± 220*** | 7,785 ± 227 | 7,856 ± 253 |
| MVC (Nm) | 285.9 ± 10.3 | 261.3 ± 11.1* | 270.6 ± 13.3 | 277.1 ± 11.3 | 265.4 ± 11.2 | 296.6 ± 12.9* |
| EMGRMS (%) | 2.26 ± 0.35 | 2.46 ± 0.60 | 2.80 ± 0.68 | 2.07 ± 0.34 | 2.22 ± 0.43 | 2.65 ± 0.74 |
| Opt. angle (°) | 74.0 ± 1.6 | 76.0 ± 1.6 | 76.0 ± 1.6 | 77.0 ± 1.5 | 75.0 ± 1.7 | 77.0 ± 2.1 |
| Plantar flexors | ||||||
| max CSA (mm2) | 5,516 ± 164 | 5,384 ± 167** | 5,578 ± 158 | 5,409 ± 150* | 5,430 ± 153 | 5,464 ± 147 |
| MVC (Nm) | 188.2 ± 12.7 | 177.5 ± 11.5 | 191.7 ± 10.8 | 186.3 ± 11.1 | 189.8 ± 12.5 | 195.0 ± 8.8 |
| EMGRMS (%) | 1.99 ± 0.47 | 2.18 ± 0.45 | 2.49 ± 0.56 | 2.78 ± 0.63 | 2.86 ± 1.09 | 3.15 ± 0.96 |
| Opt. angle (°) | −10.0 ± 0.0 | −10.0 ± 0.0 | −9.0 ± 1.0 | −10.0 ± 0.0 | −9.0 ± 1.0 | −10.0 ± 0.0 |
CSA cross-sectional area, MVC maximal voluntary isometric torque, EMG root-mean-squared amplitude of the electromyogram in percentage of M-Wave amplitude, opt. angle optimum joint angle that yielding the highest MVC
* P < 0.05, ** P < 0.01, *** P < 0.001 post different from pre
Indices of knee extensor fatigability and counter movement jump performance from CON, STA, and LRT subjects before (Pre) and after (Post) 5 days of bed rest
| Variable | CON | STA | LRT | |||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| KE TTF (s) | 57.3 ± 7.6 | 60.8 ± 6.8 | 62.6 ± 8.0 | 66.7 ± 7.2 | 65.1 ± 5.5 | 65.7 ± 5.9 |
| KE ΔEMGRMS (μV) | 69.58 ± 16.95 | 82.11 ± 23.84 | 82.77 ± 25.89 | 106.46 ± 23.22 | 93.14 ± 17.58 | 81.01 ± 20.68 |
| KE ΔEMSMF (Hz) | −12.03 ± 2.32 | −16.32 ± 3.36 | −18.93 ± 3.76 | −18.05 ± 3.18 | −17.42 ± 3.09 | −22.99 ± 3.07 |
| CMJ max (cm) | 39.87 ± 0.88 | 38.64 ± 0.97*** | 40.41 ± 1.08 | 38.56 ± 1.23*** | 39.88 ± 0.87 | 38.96 ± 0.89*** |
| CMJ min (cm) | −29.00 ± 1.24 | −29.00 ± 1.33 | −32.69 ± 1.59 | −30.80 ± 1.74 | −29.76 ± 1.26 | −29.74 ± 1.26 |
| CMJ Pmax (W/kg) | 44.29 ± 1.15 | 44.90 ± 1.20 | 44.17 ± 1.23 | 44.25 ± 1.15 | 44.24 ± 1.20 | 45.31 ± 1.22 |
| CMJ Fmax (kN) | 2.36 ± 0.04 | 2.42 ± 0.04 | 2.43 ± 0.04 | 2.40 ± 0.04 | 2.37 ± 0.05 | 2.42 ± 0.06 |
KE knee extensor, TTF time to task failure, ΔEMG the absolute change (final 2 s mean − initial 2 s mean) in root-mean-squared amplitude of the electromyogram during the fatiguing contraction, ΔRMS the absolute change (final 2 s mean − initial 2 s mean) in median frequency of the electromyogram during the fatiguing contraction, CMJ countermovement jump; max, maximum jump height; min, countermovement depth, Pmax maximum Power normalized for body mass (kg), Fmax maximum Force
*** P < 0.001 post different from pre (data pooled across interventions)
Fig. 1The day-to-day nitrogen balance (nutritional intake minus urinary excretion) during the study for the CON, STA and LRT interventions. Data are provided as mean ± SEM
Mean Nitrogen balance values for CON, STA, and LRT during baseline (BDC), bed rest (HDT) and recovery (R)
| Intervention | Absolute nitrogen balance (g) (cumulative intake − urinary excretion) | ||
|---|---|---|---|
| BDC | HDT |
| |
| CON | 8.44 ± 1.98 | 4.31 ± 1.89*** | 8.85 ± 1.89 |
| STA | 8.11 ± 2.10 | 3.08 ± 2.41*** | 7.96 ± 1.92 |
| LRT | 11.68 ± 2.24 | 9.43 ± 1.67*** | 12.01 ± 2.49 |
Values are presented as mean cumulative sums ± SEM for each intervention for each study phase
*** P < 0.001 HDT different from BDC and R+ (data pooled across interventions)
Fig. 2Time course of urinary bone resorption marker CTX throughout the study for the CON STA and LRT interventions. Data are provided as mean ± SEM. *P < 0.05, **P < 0.01 different from BDC-1
Fig. 3Time course of urinary bone resorption marker NTX throughout the study for the CON STA and LRT interventions. Data are provided as mean ± SEM. *P < 0.05
Markers of bone formation for CON, STA, and LRT during baseline (BDC), bed rest (HDT) and recovery (R)
| Bone marker | Intervention | BDC | HDT |
|
|---|---|---|---|---|
| bAP (μg/l) | CON | 10.30 ± 0.76 | 10.99 ± 0.76 | 10.38 ± 0.81 |
| STA | 10.07 ± 0.71 | 10.92 ± 0.75 | 10.66 ± 0.78 | |
| LRT | 10.42 ± 0.56 | 11.06 ± 0.63 | 10.59 ± 0.57 | |
| P1NP (μg/l) | CON | 55.90 ± 2.48 | 59.37 ± 2.67 | 54.77 ± 1.78 |
| STA | 55.03 ± 1.25 | 59.83 ± 1.37 | 56.09 ± 1.52 | |
| LRT | 53.69 ± 1.86 | 55.90 ± 1.73 | 53.71 ± 1.61 |
bAP bone-specific alkaline phosphatase, P1NP procollagen type 1 amino-terminal propeptide